Statin therapy in lupus-mediated atherogenesis: two birds with one stone?

The atherosclerotic process is accelerated in patients with systemic lupus erythematosus (SLE). In addition to a robust lipid-lowering effect, various immunomodulatory functions have been ascribed to statins. By virtue of the latter they may be able to reduce atherosclerotic vascular disease in SLE...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: van Leuven, Sander I, Mendez-Fernandez, Yanice V, Stroes, Erik S, Tak, Paul P, Major, Amy S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306212/
https://ncbi.nlm.nih.gov/pubmed/21068103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.133827
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller